Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has issued an announcement.
Zylox-Tonbridge Medical Technology Co., Ltd. has proposed the adoption of a Share Incentive Scheme, which aims to align with the company’s long-term business goals and improve its corporate governance structure. The scheme is designed to attract and retain key employees and enhance the company’s market competitiveness, subject to shareholder approval. The scheme will involve issuing new H Shares and has a duration of ten years, with specific limits on the number of shares available for issuance.
The most recent analyst rating on (HK:2190) stock is a Hold with a HK$26.00 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing medical devices and technologies, aiming to enhance market competitiveness and sustainable development.
Average Trading Volume: 649,977
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.41B
See more data about 2190 stock on TipRanks’ Stock Analysis page.